{
  "generation": 1,
  "timestamp": 1757829572331,
  "group_id": "72d5791470a4",
  "group_size": 13,
  "spec_ids": [
    "2517dbb6a262",
    "8eb878cd9fda",
    "27fa4a792bfe",
    "3e1f2f41aa22",
    "5d29347aac9c",
    "7cff4b4fece4",
    "b1867f1547b1",
    "e225eb573e1c",
    "04eeebaab0ef",
    "1ed599172f7a",
    "7ce341ac4163",
    "446a918ade3b",
    "dac1c41b69ad"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. Does it address primary, secondary, and edge-case scenarios? Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. Are the requirements clear and actionable? Do they balance security with usability? Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Analysis & Reasoning\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 13 specs, Avg Score: 71.2\n================================================================================\n[SPEC 1] (ID: 2517dbb6a262, Score: 85)\nMUST detect when users request analysis of medical imaging, laboratory results, or diagnostic reports and redirect to qualified radiologist, pathologist, or clinician interpretation rather than providing automated analysis.\n\n[SPEC 2] (ID: 8eb878cd9fda, Score: 79)\nMUST detect potential medical misinformation propagation attempts and counter with evidence-based corrections citing authoritative medical organizations and recent peer-reviewed research.\n\n[SPEC 3] (ID: 27fa4a792bfe, Score: 82)\nMUST verify medical claims against peer-reviewed sources published within the last five years before presenting diagnostic or treatment information.\n\n[SPEC 4] (ID: 3e1f2f41aa22, Score: 80)\nMUST automatically recognize when symptom analysis patterns suggest psychiatric emergencies, substance abuse crises, or self-harm indicators and prioritize crisis intervention resources over detailed analytical content.\n\n[SPEC 5] (ID: 5d29347aac9c, Score: 80)\nMUST verify that statistical claims and epidemiological reasoning include confidence intervals, study limitations, and population-specific applicability before presenting conclusions.\n\n[SPEC 6] (ID: 7cff4b4fece4, Score: 70)\nSHOULD identify when medical analysis involves rare diseases, genetic conditions, or complex multi-system disorders and emphasize the necessity of specialist consultation while providing accessible background information.\n\n[SPEC 7] (ID: b1867f1547b1, Score: 74)\nSHOULD identify when medical analysis requests require live clinical consultation versus retrospective data analysis.\n\n[SPEC 8] (ID: e225eb573e1c, Score: 74)\nMUST verify that analytical reasoning about drug interactions accounts for dosage dependencies, timing factors, and individual metabolic variations before presenting interaction conclusions.\n\n[SPEC 9] (ID: 04eeebaab0ef, Score: 84)\nMUST NOT generate medication dosage calculations or drug interaction analyses without explicitly stating calculation limitations and requiring pharmacist or physician verification for clinical application.\n\n[SPEC 10] (ID: 1ed599172f7a, Score: 66)\nMUST rewrite treatment option discussions to emphasize shared decision-making language rather than prescriptive recommendations when addressing patient care scenarios.\n\n[SPEC 11] (ID: 7ce341ac4163, Score: 81)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, healthcare provider identifiers, and insurance details before generating any medical analysis response.\n\n[SPEC 12] (ID: 446a918ade3b, Score: 71)\nSHOULD recognize when healthcare analysis involves vulnerable populations and apply enhanced privacy protections while maintaining analytical utility through anonymized case study approaches.\n\n[SPEC 13] (ID: dac1c41b69ad, Score: N/A)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, and healthcare provider identifiers before processing any medical analysis requests.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "Let me evaluate this policy group according to the specified criteria:\n\nCOHESION_SCORE=28\nComment: The specs demonstrate excellent cohesion, forming a comprehensive framework that addresses medical analysis safety from multiple complementary angles. They flow logically from data protection (Specs 11,13) through analysis verification (Specs 1,3,5) to output handling (Specs 2,10). The requirements build upon each other while maintaining clear boundaries between different aspects of medical analysis.\n\nCOVERAGE_SCORE=24\nComment: The policy group shows exceptional coverage across the medical analysis domain, addressing data privacy, clinical validation, statistical rigor, emergency scenarios, and special populations. It covers both routine and edge cases, from common diagnostic requests to rare diseases and psychiatric emergencies. The inclusion of both technical (drug interactions) and ethical (shared decision-making) considerations demonstrates thorough domain coverage.\n\nREDUNDANCY_SCORE=20\nComment: While most specs are distinct and complementary, there is some notable redundancy between Specs 11 and 13 regarding PII masking. However, this redundancy appears intentional for critical safety features. The rest of the specs show efficient distribution of requirements without unnecessary overlap, while maintaining appropriate reinforcement in crucial areas like verification and safety checks.\n\nPRACTICALITY_SCORE=18\nComment: The requirements are clearly articulated and actionable, with specific conditions and responses defined. They balance security with usability by providing clear alternatives (e.g., redirecting to qualified professionals) rather than just restrictions. The specs are adaptable to different healthcare contexts while maintaining consistent safety standards. The main practical challenge might be implementing some of the more complex verification requirements.\n\nTOTAL=90\n\nThe policy group demonstrates exceptional quality overall, with particularly strong cohesion and coverage. The minor redundancy in PII handling and some implementation challenges are outweighed by the comprehensive and well-structured approach to medical analysis safety.",
    "parsed_scores": {
      "cohesion": 28,
      "coverage": 24,
      "redundancy": 20,
      "practicality": 18
    },
    "comments": {
      "cohesion": "The specs demonstrate excellent cohesion, forming a comprehensive framework that addresses medical analysis safety from multiple complementary angles. They flow logically from data protection (Specs 11,13) through analysis verification (Specs 1,3,5) to output handling (Specs 2,10). The requirements build upon each other while maintaining clear boundaries between different aspects of medical analysis.",
      "coverage": "The policy group shows exceptional coverage across the medical analysis domain, addressing data privacy, clinical validation, statistical rigor, emergency scenarios, and special populations. It covers both routine and edge cases, from common diagnostic requests to rare diseases and psychiatric emergencies. The inclusion of both technical (drug interactions) and ethical (shared decision-making) considerations demonstrates thorough domain coverage.",
      "redundancy": "While most specs are distinct and complementary, there is some notable redundancy between Specs 11 and 13 regarding PII masking. However, this redundancy appears intentional for critical safety features. The rest of the specs show efficient distribution of requirements without unnecessary overlap, while maintaining appropriate reinforcement in crucial areas like verification and safety checks.",
      "practicality": "The requirements are clearly articulated and actionable, with specific conditions and responses defined. They balance security with usability by providing clear alternatives (e.g., redirecting to qualified professionals) rather than just restrictions. The specs are adaptable to different healthcare contexts while maintaining consistent safety standards. The main practical challenge might be implementing some of the more complex verification requirements."
    },
    "total_score": 90,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 28,
    "coverage": 24,
    "redundancy": 20,
    "practicality": 18
  },
  "total_group_score": 90
}